CROP Infrastructure Corp. (CSE:CROP) (OTC:CRXPF) (“CROP” or the “Company”) announces today it has entered into a loan agreement with Elite Ventures Group, LLC of Nevada to purchase a Nye County agricultural property with the intention of forming a joint venture development agreement for Hemp & Cannabis infrastructure. The Company has agreed to finance the Nevada project and has forwarded an initial cash commitment of $100,000 USD into escrow.

The Nye County agricultural property is in Central Nevada and was selected for its temperate climate which is ideal for greenhouse growing. The property spans over 315 acres and includes 300 acres of private water rights, with 240 acres under automatic irrigation pivots that have automatic fertilizer injection systems installed. Once licensed for hemp and cannabis, the pivots would be seeded with feminized auto flowering seeds for both THC and CBD crops. The Company’s potential cultivation infrastructure consultant believes the pivots would allow for three turns per year that would supply an abundant feedstock for the creation of both CBD and THC distillates. The property will have 50 acres set aside for building cannabis specific greenhouses. The first phase of the project development is expected to cost about $700,000 USD to seed the 240 acres with the automatic watering pivots. The acquisition is subject to a due diligence period of 45 days.


Gillian Flaccus, of The Associated Press, pointed out in the article titled Oregon marijuana growers diversify with hemp (May 14, 2018) that “In its purified distilled form, CBD oil commands thousands of dollars per kilogram, and farmers can make more than $100,000 an acre growing hemp plants to produce it.”

Nevada Hemp / CBD Industry:

Nevada has allowed hemp cultivation /production since 2016 and does not require hemp processing licenses. Under the provisions of Nevada Senate Bill 396, industrial hemp products intended for human consumption, like cannabidiol (CBD oil), can be sold in marijuana dispensaries throughout Nevada. Cannabidiol CBD products in Nevada are available for purchase over-the-counter and without a prescription. CBD is extracted from industrial hemp and because all hemp products have been made available, CBD is legal in Nevada. Industrial hemp is a variety of the Cannabis Sativa L. plant species. The terms hemp, cannabis, and marijuana all refer to the same species. Industrial hemp and marijuana are two different subspecies. One of the biggest difference is that industrial hemp has a minuscule THC content under > .3% whereas marijuana can contain a staggering 28% THC. THC is the psychotropic chemical found in cannabis meaning that industrial hemp does not share the familiar psychotropic qualities that marijuana is known for.

Nevada allows hemp production for:

  • Flower
  • Seed or seed oil
  • Fiber
  • Cannabidiol CBD

Market considerations

Nevada hemp growers surveyed by Marijuana Business Daily report that the market is fetching:

  • $200 or more per pound for flower, depending on CBD content and quality
  • About $10 per pound of food-grade seed, or $45 per gallon for seed oil
  • About $200 per ton of baled fiber
  • About $10,000 per Kg of CBD isolate

CROP Infrastructure Director & CEO, Michael Yorke, states: “With cannabis infrastructure in California, Washington, CROP is expanding its footprint and operations in some of the largest legal markets throughout the US. This property, which has abundant water rights, already has 240 acres of existing irrigation infrastructure offering a turn-key solution suitable for Hemp and Cannabis growers. The company is looking to partner with a licensed hemp grower immediately, and further invest in CBD extraction infrastructure”

About CROP

Crop Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP”. CROP is engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of projects includes licensed greenhouse facilities in California and Washington State.

Company Contact

Michael Yorke – CEO & Director

E-mail: info@cropcorp.com

Website: www.cropcorp.com

Phone: (604) 484-4206

Disclaimer for Forward-Looking Information

Certain statements in this press release related to the Offering, the securities issuable thereunder and the Transaction are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect.These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected yield from The Nye Property; the technological effects of The Nye Property on production; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

The CSE has not reviewed, approved or disapproved the content of this press release.

 

Click here to connect with CROP Infrastructure Corp. (CSE:CROP) (OTC:CRXPF)for an Investor Presentation.

Source: www.nasdaq.com

PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“PharmaTher”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to provide a corporate update on its psychedelic pharmaceuticals program. Since its inception, the Company has built a unique product pipeline for novel uses of ketamine, psilocybin and undisclosed psychedelics. PharmaTher is positioning itself to partner its psilocybin program and panaceAI™, and focus on advancing its novel ketamine product pipeline in Parkinson’s disease, depression and pain via the U.S. Food and Drug Administration (“FDA”) regulatory pathway.

“We have made tremendous progress over the last several months that saw our product pipeline evolve to focus on the massive opportunity and potential of ketamine, an FDA approved drug with a known safety profile, to treat significant unmet medical needs for Parkinson’s disease, depression and pain,” said Fabio Chianelli, CEO of PharmaTher. “With our focus on ketamine through repurposing, combining it with an FDA approved drug and delivering it with our novel microneedle delivery system, we are now positioned to expedite our clinical development objectives by taking advantage of the FDA’s 505(b)(2) regulatory pathway and commercializing disruptive ketamine treatments for mental health and pain disorders.”

Keep reading... Show less

Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or “Progressive Planet”), an emerging leader in reducing the carbon footprint of cement products using natural pozzolans, is pleased to announce it has sold and optioned a combined total of 10 million of its 10.5 million shares of Snow Lake Resources.

The sale and option agreements were made with two arms-length purchasers. The first sale was for 1,700,000 shares at $0.04 per share for a total of $68,000 and includes an option granted by PLAN entitling the same party to purchase an additional 4,966,666 shares at $0.04 per share until May 11, 2021 . The second sale was for 1,250,000 shares at $0.04 per share for a total of $50,000 and includes an option granted by PLAN to such party to purchase an additional 2,083,334 shares until August 14, 2021 . As at the date of this news release, PLAN has received $116,000 and will receive another $284,000 if the remaining shares are purchased under the option agreements.

Keep reading... Show less

First Products to Hit California Shelves in Q2 2021

 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that its fully funded state of the art 185,000 square foot production facility in Commerce, California is nearing completion and will be ready to serve the $3b California cannabis market in Q2 2021. The project is on target to be completed in April 2021 with the Company planning for the first of its full line of edibles, tinctures and vape products to be on California retail shelves by May.

Keep reading... Show less

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders – potential industry partners, shareholders and prospective investors – by increasing awareness of its remarkable natural mustard-derived crop protection products.

TODAY: The Future of Food Investment Conference – SnowCap Ventures
Tuesday, Nov. 24th at 1:50 pm ET
Investors Register Here

Keep reading... Show less

Sales to Commence Immediately at The Apothecarium Phillipsburg

 TerrAscend Corp. (“TerrAscend”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that it has received the final permit from the NJ Department of Health (“NJ DOH”) to dispense medical cannabis from its first dispensary in New Jersey . The 3,500 square-foot dispensary, located at 55 South Main Street in downtown Phillipsburg is situated in the historic Phillipsburg National Bank & Trust building and is the first Alternative Treatment Center (“ATC”) in Warren County .

Keep reading... Show less